ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

NIH Challenge Grant Announcement

March 6, 2009

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

House Reprogramming Of NCI Funds Analyzed; Community Programs Would Be Hurt

July 13, 1979

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012